RS & RS Scientific develop personalized gene therapies for lung cancer with AI-powered platform.
Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.
Contact MarcoCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.